Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY: MED )

17.76 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 Next >
Looking Into Medifast's Recent Short Interest
Via Benzinga
Three Reasons to Avoid MED and One Stock to Buy Instead
What a brutal six months it’s been for Medifast. The stock has dropped 20.6% and now trades at $19.84, rattling many shareholders. This may have investors wondering how to approach the situation. 
Via StockStory
Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3
Let’s dig into the relative performance of Nu Skin (NYSE:NUS) and its peers as we unravel the now-completed Q3 personal care earnings season. 
Via StockStory
Topics Economy
Exposures Economy
Personal Care Stocks Q3 Teardown: Olaplex (NASDAQ:OLPX) Vs The Rest
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the personal care stocks, including Olaplex (NASDAQ:OLPX) and its peers. 
Via StockStory
Topics Economy
Exposures Economy
Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at personal care stocks, starting with... 
Via StockStory
Topics Economy
Exposures Economy
Looking Into Medifast's Recent Short Interest
Via Benzinga
(MED) - Analyzing Medifast's Short Interest
Via Benzinga
Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For
Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here’s what investors should know. 
Via StockStory
Nu Skin Earnings: What To Look For From NUS
Personal care company Nu Skin (NYSE:NUS) will be reporting earnings tomorrow after the bell. Here’s what to expect. 
Via StockStory
Edgewell Personal Care (EPC) Q3 Earnings: What To Expect
Personal care company Edgewell Personal Care (NYSE:EPC) will be announcing earnings results tomorrow before the bell. Here’s what to expect. 
Via StockStory
Olaplex (OLPX) To Report Earnings Tomorrow: Here Is What To Expect
Hair care company Olaplex (NASDAQ:OLPX) will be announcing earnings results tomorrow before the bell. Here’s what to look for. 
Via StockStory
Medifast (NYSE:MED) Posts Better-Than-Expected Sales In Q3 But Quarterly Guidance Underwhelms
Wellness company Medifast (NYSE:MED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell 40.6% year on year to $140.2 million. On the other hand, next quarter’s... 
Via StockStory
Medifast (MED) To Report Earnings Tomorrow: Here Is What To Expect
Wellness company Medifast (NYSE:MED) will be reporting results tomorrow after market hours. Here’s what investors should know. 
Via StockStory
MED Stock Earnings: Medifast Beats EPS, Beats Revenue for Q2 2024
MED stock results show that Medifast beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Time to Unload: 3 Stocks in Deep Trouble to Sell Now
Discover three stocks to sell now. Even with bullish market conditions, read on to learn why these companies are doomed. 
Via InvestorPlace
7 Consumer Staples Stocks to Buy at a 52-Week Low in July
If the long-awaited sector rotation is happening, it’s time to look at these undervalued consumer staples stocks. 
Via InvestorPlace
3 Overlooked Telehealth Stocks Poised for a Comeback
Telehealth stocks are on the rise as firms expand virtual healthcare services, boosting patient outcomes and engagement. 
Via InvestorPlace
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025. 
Via InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
GLP-1s are a weight-loss breakthrough, but these three stocks to sell have a lot to lose from their rapid rise in popularity. 
Via InvestorPlace
7 Small-Cap Value Stocks Leaving the S&P 500 in the Dust
These small-cap value stocks remain an overlooked market segment despite their inherent strength and outperformance likelihood. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
KKR and GoDaddy also will join before the open on June 24. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
7 Underappreciated Stocks With 25% Return Potential in 2024
Each of these underappreciated stocks is expected to provide 25%+ returns this year, which is reason enough to pay attention. 
Via InvestorPlace
Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong
These undervalued stocks to buy offer an alternative to dipping your toes back into meme stock mania. Remember how it turned out last time? 
Via InvestorPlace
Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar
Small-cap value stocks offer stability and continued upside as big-name stocks soak up investor attention despite overvaluation. 
Via InvestorPlace
Top 4 Defensive Stocks You'll Regret Missing This Quarter
Via Benzinga
Gold Down Over 2%; 3M Profit Beats Expectations
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views
Via Benzinga
Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Coursera (COUR) Stock Down 16% Today?
Coursera stock is falling on Tuesday as COUR investors react to the company's lackluster guidance in its latest earnings report. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.